A newer seller and community nickname, commonly described as a Wolverine-style BPC-157 and TB-500 base with Cartalax (AED) added — but the formulation is not standardised.
What the name is used to mean
- 'Deadpool' is an emerging nickname rather than a compound. It is most often described online as the Wolverine pairing with Cartalax (AED) added, following the same comic-book naming habit as 'Wolverine'.
- That description is what people say the name means. It is not a specification: the Registry has identified no standard, no consistent ingredient list and no independent analysis establishing what products sold under this name contain.
- Do not assume that two things labelled 'Deadpool' contain the same ingredients, or the same number of ingredients.
- Cartalax is a short peptide whose published record is cell-culture work. Adding it to a mixture does not bring human evidence with it, because there is no human efficacy evidence to bring.
Documented readings of the name
BPC-157 + TB-500 + Cartalax (AED) — the commonly described reading
The description most often repeated online. Recorded as a reported reading only; the Registry does not state that any particular product matches it.
- BPC-157
- TB-500May be a thymosin beta-4 fragment rather than the full-length peptide.
- Cartalax (AED, Ala-Glu-Asp)A short peptide bioregulator whose published evidence is cell-culture work, with no controlled human efficacy evidence.
Combination evidence: No controlled human trial of this combination, as a combination, was identified in the curated record. None of the components has controlled human efficacy evidence for the uses claimed for this nickname, and combining them creates a new, untested product rather than pooling three evidence bases.
Read this first: Read the actual ingredient list, not the nickname. 'Deadpool' does not identify a formulation, and no analysis in the curated record establishes what any given product sold under this name contains.
Sources and review date
Last reviewed 2026-09-22
- No controlled human trial of this combination, as a combination, was identified in the curated record.
- No independent analytical study of products marketed under this nickname identified — source curation pending.